IFF eyeing acquisitions again as it sells off pharma unit—but no more ‘Frutaroms’

[
On a call with Wall Street analysts after the Fortune 500 company reported its 2024 results, CEO Erik Fyrwald made it clear that acquisitions were back on the table—but with a more disciplined approach. Read More
https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-877108494-e1740131267976.jpg?resize=1200,600
https://fortune.com/2025/02/21/iff-eyeing-acquisitions-again-sells-pharma-unit-no-more-frutaroms/


Ian Mount